Results 11 to 20 of about 15,417,439 (399)
Journal of the American Medical Association (JAMA), 2022 Importance The effects of tirzepatide, a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, as an addition to insulin glargine for treatment of type 2 diabetes have not been described.
D. Dahl +6 more
semanticscholar +1 more source
Journal of Diabetes Research, 2023 Background Glycated hemoglobin (HbA1c) is a commonly used clinical marker to monitor the control of type 2 diabetes mellitus patients (T2DM). However, it is unable to identify the ongoing inflammatory changes in the body.
Tiruneh Adane +6 more
semanticscholar +1 more source
Sex Differences in the Effects of CDKAL1 Variants on Glycemic Control in Diabetic Patients: Findings from the Korean Genome and Epidemiology Study [PDF]
Diabetes & Metabolism Journal, 2022 Background Using long-term data from the Korean Genome and Epidemiology Study, we defined poor glycemic control and investigated possible risk factors, including variants related to type 2 diabetes mellitus (T2DM).
Hye Ah Lee, Hyesook Park, Young Sun Hong
doaj +1 more source
Polyphenols and Glycemic Control [PDF]
Nutrients, 2016 Growing evidence from animal studies supports the anti-diabetic properties of some dietary polyphenols, suggesting that dietary polyphenols could be one dietary therapy for the prevention and management of Type 2 diabetes. This review aims to address the potential mechanisms of action of dietary polyphenols in the regulation of glucose homeostasis and ...
Yoona Kim, Jennifer Keogh, Peter Clifton
openaire +3 more sources
Glycemic Control for Type 2 Diabetes Mellitus Patients: A Systematic Review
Cureus, 2022 Diabetes mellitus is a chronic metabolic disorder resulting in hyperglycemia and microvascular and macrovascular complications in individuals globally. Type 2 diabetes mellitus (T2DM) is highly prevalent and accounts for 90% of patients.
S. A. Bin Rakhis +4 more
semanticscholar +1 more source
BMC Endocrine Disorders, 2022 Background The goals of glycemic management for patients with diabetes are to prevent or delay complications and optimize quality of life. However, in clinical practice, the recommended glycemic control target is difficult to achieve.
Rodas Getachew Abera +2 more
semanticscholar +1 more source
BMC Endocrine Disorders, 2022 Background Glycemic control is an important part of diabetes management. Strict glycemic control has been shown to reduce the long-term complications of diabetes. However, achieving good glycemic control is challenging for people with diabetes especially
Mulugeta Sitot Shibeshi +3 more
doaj +1 more source
BMJ Open Diabetes Research & Care, 2021 Introduction Lockdown measures have a profound effect on many aspects of daily life relevant for diabetes self-management. We assessed whether lockdown measures, in the context of the COVID-19 pandemic, differentially affect perceived stress, body weight,
M. Ruissen +10 more
semanticscholar +1 more source
BMC Cardiovascular Disorders, 2023 Background Diabetes increases the risk of hypertension morbidity, but whether this association is varied with glycemic control remains unknown. We aimed to examine the association of glycemic control with hypertension among individuals with diabetes ...
Shengliang Chen +6 more
doaj +1 more source
Diabetology & Metabolic Syndrome, 2021 Background In 2019, a new virus known as severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has emerged. Coronavirus disease 2019 (COVID-19) was classified as a pandemic in a short period of time. In order to reduce the spread of COVID-19,
C. Eberle, Stefanie Stichling
semanticscholar +1 more source